425 related articles for article (PubMed ID: 22728558)
1. [Contingent diagnosis of sarcoidosis by 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) after completion of chemotherapy for malignant lymphoma].
Iino M; Iizuka C
Rinsho Ketsueki; 2012 May; 53(5):540-2. PubMed ID: 22728558
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.
Kaira K; Oriuchi N; Otani Y; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Endo K; Mori M
Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of sarcoidosis-lymphoma syndrome lesions: a case report on the use of two different positron emission tomography tracers.
Yudistiro R; Arisaka Y; Tokue A; Nakajima T
BMC Med Imaging; 2016 Jan; 16():1. PubMed ID: 26746426
[TBL] [Abstract][Full Text] [Related]
4. The scar sign: a useful finding on FDG PET/CT to distinguish sarcoidosis from other causes of lymphadenopathy.
Lu SJ; Lee VK; Loo SW
Clin Nucl Med; 2013 Mar; 38(3):205-8. PubMed ID: 23354040
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis.
Nishiyama Y; Yamamoto Y; Fukunaga K; Takinami H; Iwado Y; Satoh K; Ohkawa M
J Nucl Med; 2006 Oct; 47(10):1571-6. PubMed ID: 17015889
[TBL] [Abstract][Full Text] [Related]
6. [Sarcoidosis-lymphoma syndrome showing abnormal FDG uptake in lymph nodes and muscles upon post-chemotherapy PET/CT imaging].
Nakano K; Ito Y; Takagi F; Uchiyama S; Yoda A; Sakamoto N; Takaba M; Adachi M; Takemura T; Nagata Y; Ono T
Rinsho Ketsueki; 2019; 60(4):302-307. PubMed ID: 31068560
[TBL] [Abstract][Full Text] [Related]
7. Use of integrated FDG-PET/CT in sarcoidosis.
Krüger S; Buck AK; Mottaghy FM; Pauls S; Schelzig H; Hombach V; Reske SN
Clin Imaging; 2008; 32(4):269-73. PubMed ID: 18603181
[TBL] [Abstract][Full Text] [Related]
8. Cervical and axillary lymph node sarcoidosis misdiagnosed as lymphoma on F-18 FDG PET-CT.
Li YJ; Zhang Y; Gao S; Bai RJ
Clin Nucl Med; 2007 Mar; 32(3):262-4. PubMed ID: 17314619
[No Abstract] [Full Text] [Related]
9. Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy.
Aide N; Benayoun M; Kerrou K; Khalil A; Cadranel J; Talbot JN
Br J Radiol; 2007 Mar; 80(951):e67-71. PubMed ID: 17548505
[TBL] [Abstract][Full Text] [Related]
10. Diffuse renal (18)F-FDG uptake of a patient with fever of unknown origin revealed sarcoidosis.
Toyonaga T; Manabe O; Gaertner FC; Nakagaki T; Nishio S; Suzuki A; Tamaki N
Clin Nucl Med; 2014 Jul; 39(7):648-9. PubMed ID: 24873783
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of fluorodeoxyglucose-positron emission tomography in a case of pleural sarcoidosis].
Hattori T; Konno S; Inomata T; Nasuhara Y; Betsuyaku T; Nishimura M
Nihon Kokyuki Gakkai Zasshi; 2009 Jul; 47(7):658-62. PubMed ID: 19637812
[TBL] [Abstract][Full Text] [Related]
12. False-positive finding in FDG-PET in a patient with seminoma and sarcoidosis.
Liepe K
Acta Clin Belg; 2015 Apr; 70(2):138-40. PubMed ID: 25409626
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis.
Ozawa Y; Yamamoto H; Yasuo M; Komatsu M; Ushiki A; Hamano H; Uehara T; Kawakami S; Fujita A; Fujinaga Y; Oguchi K; Kawa S; Hanaoka M
Nagoya J Med Sci; 2020 Feb; 82(1):101-111. PubMed ID: 32273638
[TBL] [Abstract][Full Text] [Related]
14. Combined C-11 methionine and F-18 FDG PET imaging in a case of neurosarcoidosis.
Ng D; Jacobs M; Mantil J
Clin Nucl Med; 2006 Jul; 31(7):373-5. PubMed ID: 16785800
[TBL] [Abstract][Full Text] [Related]
15. FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports.
Takanami K; Kaneta T; Yamada T; Kinomura S; Yamada S; Fukuda H; Takahashi S
Clin Nucl Med; 2008 Apr; 33(4):258-61. PubMed ID: 18356663
[TBL] [Abstract][Full Text] [Related]
16. Dramatic change in 18F-FDG uptake in a sarcoidosis case showing spontaneous recovery.
Ito K; Miyata Y; Minamimoto R; Kubota K
Clin Nucl Med; 2014 Apr; 39(4):376-8. PubMed ID: 23640228
[TBL] [Abstract][Full Text] [Related]
17. [Value of 18F-fluorodeoxyglucose-PET in the diagonosis and monitoring of pulmonary sarcoidosis: a case report].
Kaneko M; Tomioka H; Kaneda T; Kubot M; Tani S; Fujii H; Katsuyama E; Okazaki M
Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):505-9. PubMed ID: 18593000
[TBL] [Abstract][Full Text] [Related]
18. [Sarcoidosis-lymphoma syndrome].
Partanen A; Pukkila S; Jantunen E
Duodecim; 2016; 132(7):661-5. PubMed ID: 27188091
[TBL] [Abstract][Full Text] [Related]
19. Laryngeal sarcoidosis detected by FDG positron emission tomography.
Kaira K; Ishizuka T; Yanagitani N; Sunaga N; Hisada T; Mori M
Clin Nucl Med; 2008 Dec; 33(12):878-9. PubMed ID: 19033796
[TBL] [Abstract][Full Text] [Related]
20. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
